NTRK2 and neoplasm: TrkB. The altered expression and the occurrence of genetic mutations affecting tropomyosin-related kinase B receptor (TrkB), have been proven to play an essential role for tumor progression as observed by the increase of invasion, metastasis, angiogenesis, and resistance against therapeutic treatments.